Blood Products: Difference between revisions
No edit summary |
No edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Stub Notice}} | {{Stub Notice}} | ||
[https://pubs.asahq.org/anesthesiology/article/140/1/144/138661/What-s-in-Your-Transfusion-A-Bedside-Guide-to What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation] | |||
[https://pubmed.ncbi.nlm.nih.gov/37144721/ Error traps in Pediatric Patient Blood Management in the Perioperative Period] | |||
[https://journals.lww.com/ejanaesthesiology/abstract/9000/peri_operative_red_blood_cell_transfusion_in.98150.aspx Peri-operative red blood cell transfusion in neonates and infants] | [https://journals.lww.com/ejanaesthesiology/abstract/9000/peri_operative_red_blood_cell_transfusion_in.98150.aspx Peri-operative red blood cell transfusion in neonates and infants] | ||
Line 38: | Line 42: | ||
[https://pubs.asahq.org/anesthesiology/article/140/1/144/138661/What-s-in-Your-Transfusion-A-Bedside-Guide-to What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation] | [https://pubs.asahq.org/anesthesiology/article/140/1/144/138661/What-s-in-Your-Transfusion-A-Bedside-Guide-to What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation] | ||
[https://www.sciencedirect.com/science/article/pii/S001236922400285X Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines] | |||
<b>Massive Transfusion/Hemorrhage Protocol</b> | <b>Massive Transfusion/Hemorrhage Protocol</b> | ||
[https://pubmed.ncbi.nlm.nih.gov/33494884/ Massive Transfusion in Pediatric Patients] | [https://pubmed.ncbi.nlm.nih.gov/33494884/ Massive Transfusion in Pediatric Patients] | ||
Line 64: | Line 69: | ||
[https://pubmed.ncbi.nlm.nih.gov/3970376/ Changes in serial platelet counts following massive blood transfusion in pediatric patients] | [https://pubmed.ncbi.nlm.nih.gov/3970376/ Changes in serial platelet counts following massive blood transfusion in pediatric patients] | ||
<b>Reducing blood draw anemia</b> | |||
[https://link.springer.com/article/10.1007/s12630-023-02643-8 Effect of using smaller blood volume tubes and closed blood collection devices on total blood loss in patients undergoing major cardiac and vascular surgery] | |||
[https://link.springer.com/article/10.1007/s12630-023-02548-6 Small-volume tubes to reduce anemia and transfusion (STRATUS): a pilot study] | |||
[https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2511-9 Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review] | |||
Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med. 2019 Apr 4; 380(14): 1326-1335. PMID: 30730782 | |||
Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015 Dec 17; 373(25): 2413-24. PMID: 26559317 |
Latest revision as of 18:07, 7 November 2024
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation
Error traps in Pediatric Patient Blood Management in the Perioperative Period
Peri-operative red blood cell transfusion in neonates and infants
Pediatric preoperative blood ordering: when is a type and screen or crossmatch really needed?
Massive transfusion in pediatric trauma-does more blood predict mortality?
How to manage coagulopathies in critically ill patients
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient
Prehospital tranexamic acid for trauma victims
Error traps in Pediatric Patient Blood Management in the Perioperative Period
Pediatric Blood Transfusion Therapy and Patient Blood Management
Federici AB. Clinical and laboratory diagnosis of VWD. Hematology Am Soc Hematol Educ Program. 2014 Dec; 2014(1): 524-30. PMID: 25696905
Neff AT, Sidonio RF Jr. Management of VWD. Hematology Am Soc Hematol Educ Program. 2014 Dec; 2014(1): 536-41. PMID: 25696907
WHO: The urgent need to implement patient blood management: policy brief
What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation
Massive Transfusion/Hemorrhage Protocol
Massive Transfusion in Pediatric Patients
Pediatric Massive Transfusion: A Systematic Review
Massive Transfusion Protocols for Pediatric Patients: Current Perspectives
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics
Boston Children’s Hospital que Massive Hemorrhage Guidelines
Single-Center Use of Prothrombin Complex Concentrate in Pediatric Patients
Prothrombin Complex Concentrate Utilization in Children's Hospitals
Changes in serial platelet counts following massive blood transfusion in pediatric patients
Reducing blood draw anemia
Small-volume tubes to reduce anemia and transfusion (STRATUS): a pilot study
Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review
Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med. 2019 Apr 4; 380(14): 1326-1335. PMID: 30730782
Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015 Dec 17; 373(25): 2413-24. PMID: 26559317